The early treatment levels of C-reactive protein (CRP) and lactate dehydrogenase (LDH), instead of their pretreatment baseline levels, are found to significantly associate with one-year OS of ICI-treated NSCLC patients (11). Here, CRP is linked to non-small cell lung carcinoma.